Sayed Mahmood Alqallaf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sayed Mahmood Alqallaf has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Abdulrahman Musiager
Nutrition and Health Studies Unit Deanship of Scientific Research, University of Bahrain, Sakheer, Kingdom of Bahrain
1 shared publicationBaj Evans
Department of Child Health, School of Medicine, Cardiff University, Cardiff, UK
1 shared publicationEj Kidd
Welsh School of Pharmacy, Cardiff University, Cardiff, UK, and
1 shared publicationFatema Alshaikh
Pharmacy Program, Allied Health Sciences Department, College of Health Sciences, University of Bahrain
1 shared publication- Fatima Ahmed Al-Haddad
Dietetic Unit for Hospitals, Pediatric Department, Salmaniya Medical Complex, Kingdom of Bahrain
1 shared publication - Ghufran Jassim
Family Medicine Department, School of Medicine, Royal College of Surgeons in Ireland (RCSI)-Medical University of Bahrain, Busaiteen, Bahrain
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by MDPI AG in Preprints.org
Prevention Without Eradication: What Nine Device-Associated Infection Trials Reveal About the Translational Failure of Antibiofilm Therapy
Biofilms on implanted devices tolerate antibiotics and host defences, and established device infection is usually treated by removing the device. This review examines the clinical trial record across nine implanted-device settings. A consistent asymmetry emerges: every intervention that has reached approval or guideline endorsement prevents biofilm formation on an uninfected device by delivering an antimicrobial locally in a high-risk population, whereas attempts to eradicate established biofilm remain conflicting or uncontrolled. Trials that failed did so largely for reasons unrelated to antibiofilm pharmacology, including endpoints measuring colonisation rather than disease, extrapolation from animal models, event rates too low for feasible sample sizes, manufacturing instability and sponsor insolvency. Silver illustrates the problem, showing consistent laboratory activity but no benefit in adequately powered trials. The principal obstacle may therefore be the design of trials rather than the discovery of new molecules.
- 4 November 2026
- Published by MDPI AG in Preprints.org
Open AccessPrevention Without Eradication: What Nine Device-Associated Infection Trials Reveal About the Translational Failure of Antibiofilm Therapy
Biofilms on implanted devices tolerate antibiotics and host defences, and established device infection is usually treated by removing the device. This review examines the clinical trial record across nine implanted-device settings. A consistent asymmetry emerges: every intervention that has reached approval or guideline endorsement prevents biofilm formation on an uninfected device by delivering an antimicrobial locally in a high-risk population, whereas attempts to eradicate established biofilm remain conflicting or uncontrolled. Trials that failed did so largely for reasons unrelated to antibiofilm pharmacology, including endpoints measuring colonisation rather than disease, extrapolation from animal models, event rates too low for feasible sample sizes, manufacturing instability and sponsor insolvency. Silver illustrates the problem, showing consistent laboratory activity but no benefit in adequately powered trials. The principal obstacle may therefore be the design of trials rather than the discovery of new molecules.
- Open Access
- 29 October 2026
- Published by MDPI AG in Preprints.org
Beyond Glycaemic Control: Efficacy and Safety of Newer Antidiabetic Agents in Patients with Cardiorenal Disease—A Narrative Review
Cardiovascular disease and chronic kidney disease are the leading causes of death in type 2 diabetes, and lowering glycated haemoglobin alone does not adequately address this risk. This narrative review summarises evidence on the glycaemic efficacy, cardiorenal outcomes and safety of sodium–glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonist tirzepatide, dipeptidyl peptidase-4 inhibitors and once-weekly basal insulins, with attention to the Gulf region. PubMed/MEDLINE, ScienceDirect and Google Scholar were searched for trials, meta-analyses and guidelines published between 2015 and 2026. SGLT2i provide the most consistent reductions in heart failure hospitalisation and kidney disease progression, irrespective of diabetes status. GLP-1 RAs reduce major adverse cardiovascular events, stroke and kidney outcomes. Tirzepatide offers the greatest glycaemic and weight benefits, with cardiovascular protection comparable to an established GLP-1 RA. Dipeptidyl peptidase-4 inhibitors and weekly insulins are largely cardiorenal-neutral. Combining SGLT2i and GLP-1 RAs may provide additive protection. In the Middle East and North Africa, which has the highest diabetes prevalence worldwide, use of these organ-protective agents remains low. Therapy should be selected according to comorbidity, giving organ protection the same priority as glycaemic control.
- 29 October 2026
- Published by MDPI AG in Preprints.org
Open AccessBeyond Glycaemic Control: Efficacy and Safety of Newer Antidiabetic Agents in Patients with Cardiorenal Disease—A Narrative Review
Cardiovascular disease and chronic kidney disease are the leading causes of death in type 2 diabetes, and lowering glycated haemoglobin alone does not adequately address this risk. This narrative review summarises evidence on the glycaemic efficacy, cardiorenal outcomes and safety of sodium–glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonist tirzepatide, dipeptidyl peptidase-4 inhibitors and once-weekly basal insulins, with attention to the Gulf region. PubMed/MEDLINE, ScienceDirect and Google Scholar were searched for trials, meta-analyses and guidelines published between 2015 and 2026. SGLT2i provide the most consistent reductions in heart failure hospitalisation and kidney disease progression, irrespective of diabetes status. GLP-1 RAs reduce major adverse cardiovascular events, stroke and kidney outcomes. Tirzepatide offers the greatest glycaemic and weight benefits, with cardiovascular protection comparable to an established GLP-1 RA. Dipeptidyl peptidase-4 inhibitors and weekly insulins are largely cardiorenal-neutral. Combining SGLT2i and GLP-1 RAs may provide additive protection. In the Middle East and North Africa, which has the highest diabetes prevalence worldwide, use of these organ-protective agents remains low. Therapy should be selected according to comorbidity, giving organ protection the same priority as glycaemic control.
- Open Access
- 26 July 2022
- Published by Clujul Medical in Medicine and Pharmacy Reports
- Vol. 95 (3) , 320-331
Medication-related burden from the perspective of the elderly
Living with extensive polypharmacy among the elderly population affects their quality of lives and medication compliance. The UK-developed (LMQ-3) which is a valid instrument designed to quantify medicine burden. The objectives of this study were to quantify medicines burden among community-dwelling elderly, describe the numbers and types of drugs used, and identify the risk factors that might need to be addressed. The descriptive cross-sectional study is designed to interview 500 Bahraini over 65 years of age using LMQ-3 questionnaire. Sample size was determined by Sloven’s formula. Data on socio-demographic characteristics and medication consumption patterns were collected then LMQ-3 and domains scores were compared by patient characteristics using descriptive statistics and statistical tests. Results found a wide range of burden among participants in Bahrain; ranging from moderate burden in almost a third of participants to high burden over two- thirds of participants. Burden was mainly driven by concerns about medicines, interferences of medicines with daily life and side effects. Higher LMQ-3 scores were associated with those who were employed, technical, aged ≥75 years, using ≥9 medicines, or using medicines four times a day. Anti-diabetics were the most prescribed medicines for the elderly. In conclusion, over two- thirds of participants experienced high burden. Being employed, technical, aged ≥75 years, using ≥9 medicines, or using medicines 4 times a day had the highest burden. These groups should become the main target for practitioners and pharmacists. Future studies should document potential herb-drug interactions among the elderly.
- 26 July 2022
- Published by Clujul Medical in Medicine and Pharmacy Reports
- Vol. 95 (3) , 320-331
Open AccessMedication-related burden from the perspective of the elderly
Living with extensive polypharmacy among the elderly population affects their quality of lives and medication compliance. The UK-developed (LMQ-3) which is a valid instrument designed to quantify medicine burden. The objectives of this study were to quantify medicines burden among community-dwelling elderly, describe the numbers and types of drugs used, and identify the risk factors that might need to be addressed. The descriptive cross-sectional study is designed to interview 500 Bahraini over 65 years of age using LMQ-3 questionnaire. Sample size was determined by Sloven’s formula. Data on socio-demographic characteristics and medication consumption patterns were collected then LMQ-3 and domains scores were compared by patient characteristics using descriptive statistics and statistical tests. Results found a wide range of burden among participants in Bahrain; ranging from moderate burden in almost a third of participants to high burden over two- thirds of participants. Burden was mainly driven by concerns about medicines, interferences of medicines with daily life and side effects. Higher LMQ-3 scores were associated with those who were employed, technical, aged ≥75 years, using ≥9 medicines, or using medicines four times a day. Anti-diabetics were the most prescribed medicines for the elderly. In conclusion, over two- thirds of participants experienced high burden. Being employed, technical, aged ≥75 years, using ≥9 medicines, or using medicines 4 times a day had the highest burden. These groups should become the main target for practitioners and pharmacists. Future studies should document potential herb-drug interactions among the elderly.
- Open Access
- 7 December 2018
- Published by Springer Nature in BMC Medical Education
- Vol. 18 (1) , 300
Knowledge of health professional students on waterpipe tobacco smoking: curricula implications
Tobacco prevention research traditionally focuses upon cigarette smoking, but there is also a need to implement and evaluate the usefulness of waterpipe tobacco smoking (WTS) interventions since it is considered less harmful than cigarettes. This study aimed to assess the impact of an educational intervention on WTS knowledge of health professional students in three academic health institutions in Bahrain. A quasi-experimental design was used to include medical students from the Arabian Gulf University, medical and nursing students from the Royal College of Surgeons in Ireland-Bahrain and nursing students from the University of Bahrain. Two hundred fifty students participated in the three phases of the study during October 2015–June 2016 from an original sample of 335. The participants answered knowledge questions on WTS before and after an intervention, which included a lecture by an expert and a video on the awareness about the health hazards of WTS. The mean age of starting cigarette and WTS was 16.8 ± 2.8 and 17.5 ± 1.7 years, respectively. The prevalence of ever smoking any type of tobacco among students was 22.4% (medical 25.8% and nursing 37.5%) and that of WTS, 17.7% (medical 20.0%, nursing 13.6%). The prevalence of current cigarette smoking was 9.6% among medical and nursing students combined with 10.3 and 8.5% for medical and nursing students, respectively. WTS was prevalent at a proportion of 6.8% among medical and nursing students combined with 6.5% in medical and 14.8% in nursing students. The university curriculum as the main source of knowledge on WTS increased from 14.2 to 33.3% after the intervention (p < 0.005). Knowledge about the hazards of WTS increased in 16 of the 20 statements. The difference in overall knowledge score was significant (p < 0.05) for nursing (77. 5 ± 1.5 vs 85.8 ± 2.2) compared to medical students (85.3 ± 1.0 vs 87.3 ± 0.9) after the intervention. Our educational intervention with health professional students improved their knowledge about the health effects of WTS. Medical and nursing institutions may consider using various methods such as informative videos and expert lectures to include in their teaching curricula as part of WTS prevention strategies.
- 7 December 2018
- Published by Springer Nature in BMC Medical Education
- Vol. 18 (1) , 300
Open AccessKnowledge of health professional students on waterpipe tobacco smoking: curricula implications
Tobacco prevention research traditionally focuses upon cigarette smoking, but there is also a need to implement and evaluate the usefulness of waterpipe tobacco smoking (WTS) interventions since it is considered less harmful than cigarettes. This study aimed to assess the impact of an educational intervention on WTS knowledge of health professional students in three academic health institutions in Bahrain. A quasi-experimental design was used to include medical students from the Arabian Gulf University, medical and nursing students from the Royal College of Surgeons in Ireland-Bahrain and nursing students from the University of Bahrain. Two hundred fifty students participated in the three phases of the study during October 2015–June 2016 from an original sample of 335. The participants answered knowledge questions on WTS before and after an intervention, which included a lecture by an expert and a video on the awareness about the health hazards of WTS. The mean age of starting cigarette and WTS was 16.8 ± 2.8 and 17.5 ± 1.7 years, respectively. The prevalence of ever smoking any type of tobacco among students was 22.4% (medical 25.8% and nursing 37.5%) and that of WTS, 17.7% (medical 20.0%, nursing 13.6%). The prevalence of current cigarette smoking was 9.6% among medical and nursing students combined with 10.3 and 8.5% for medical and nursing students, respectively. WTS was prevalent at a proportion of 6.8% among medical and nursing students combined with 6.5% in medical and 14.8% in nursing students. The university curriculum as the main source of knowledge on WTS increased from 14.2 to 33.3% after the intervention (p < 0.005). Knowledge about the hazards of WTS increased in 16 of the 20 statements. The difference in overall knowledge score was significant (p < 0.05) for nursing (77. 5 ± 1.5 vs 85.8 ± 2.2) compared to medical students (85.3 ± 1.0 vs 87.3 ± 0.9) after the intervention. Our educational intervention with health professional students improved their knowledge about the health effects of WTS. Medical and nursing institutions may consider using various methods such as informative videos and expert lectures to include in their teaching curricula as part of WTS prevention strategies.
- 1 August 2018
- Vol. 19 (8) , 2299-2304
Knowledge of Colorectal Cancer Symptoms and Risk Factors in the Kingdom of Bahrain: a Cross- Sectional Study
Background: Colorectal cancer (CRC) is second in incidence rates in both genders in the Kingdom of Bahrain, with the number of new CRC cases sharply increasing in the last two decades. This study aimed to assess the levels of knowledge regarding CRC among people living in the Kingdom. Methods: A cross-sectional survey design was used to recruit a convenient sample of 505 adults aged 25 years or above. Face to face structured interviews were conducted to supplement data gained from the questionnaire. Results: The mean age of participants was 37 (±10.43) years. Changes in bowel habits were the most commonly identified symptoms (46%) followed by lower abdominal pain (44%). Family history was the most commonly identified risk factor (38%) followed by smoking (28%). The overall score of knowledge of CRC was 56 (±18.4). The scores for symptoms and risk factors were 59 (±26.2) and 53 (±17.5) respectively. It was found that female participants had better knowledge 59 (±17) than males 54 (±19) (P = .001). Participants with high levels of education had better knowledge (63%) compared with other groups, although this was not statistically significant (P = .067). Conclusion: This study indicates poor knowledge among people living in Bahrain regarding CRC symptoms and risk factors. Strategies and educational initiatives need to be implemented to enhance the general public’s awareness in this respect.
- 1 August 2018
- Vol. 19 (8) , 2299-2304
Knowledge of Colorectal Cancer Symptoms and Risk Factors in the Kingdom of Bahrain: a Cross- Sectional Study
Background: Colorectal cancer (CRC) is second in incidence rates in both genders in the Kingdom of Bahrain, with the number of new CRC cases sharply increasing in the last two decades. This study aimed to assess the levels of knowledge regarding CRC among people living in the Kingdom. Methods: A cross-sectional survey design was used to recruit a convenient sample of 505 adults aged 25 years or above. Face to face structured interviews were conducted to supplement data gained from the questionnaire. Results: The mean age of participants was 37 (±10.43) years. Changes in bowel habits were the most commonly identified symptoms (46%) followed by lower abdominal pain (44%). Family history was the most commonly identified risk factor (38%) followed by smoking (28%). The overall score of knowledge of CRC was 56 (±18.4). The scores for symptoms and risk factors were 59 (±26.2) and 53 (±17.5) respectively. It was found that female participants had better knowledge 59 (±17) than males 54 (±19) (P = .001). Participants with high levels of education had better knowledge (63%) compared with other groups, although this was not statistically significant (P = .067). Conclusion: This study indicates poor knowledge among people living in Bahrain regarding CRC symptoms and risk factors. Strategies and educational initiatives need to be implemented to enhance the general public’s awareness in this respect.
- Open Access
- 1 January 2016
- Published by Open Science Publishers LLP in Journal of Applied Pharmaceutical Science
- Vol. 6 (6) , 091-095
Efficacy and Safety of Metformin in Weight Loss in Bahraini Population
- 1 January 2016
- Published by Open Science Publishers LLP in Journal of Applied Pharmaceutical Science
- Vol. 6 (6) , 091-095
Open AccessEfficacy and Safety of Metformin in Weight Loss in Bahraini Population
- Open Access
- 1 January 2016
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. 9, 11-16
Assessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain
Assessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain Fatima Ahmed Al-Haddad,1 Mansoor H Rajab,2 S Mahmood Al-Qallaf,3 Abdulrahman O Musaiger,4 Kathryn H Hart5 1Dietetic Unit for Hospitals, 2Pediatric Endocrine and Diabetes Team, Pediatric Department, Salmaniya Medical Complex, 3Pharmacy Program, College of Health Sciences, University of Bahrain, Manama, 4Nutrition and Health Studies Unit Deanship of Scientific Research, University of Bahrain, Sakheer, Kingdom of Bahrain; 5School of Biosciences and Medicine, Department of Nutritional Sciences, University of Surrey, Guildford, UK Background: The number of children being diagnosed with type 1 diabetes mellitus (T1DM) is on the rise and has more than doubled in the past 10 years in Bahrain. Some studies have linked low vitamin D levels with an increased risk of diabetes. There are concerns regarding the variations in circulating 25(OH)D levels measured by different laboratories and by using different analytical techniques. Objective: The aim of this study was to evaluate the vitamin D levels of newly diagnosed children with T1DM using the “gold standard method” with high-pressure liquid chromatography–tandem mass spectrometry methods compared to the chemiluminescence micro-particle immunoassay (CMIA) used in a hospital laboratory. Subjects: Eighteen children, aged 6–12 years, who received a confirmed diagnosis of T1DM in 2014 were chosen as subjects. Methods: Serum vitamin D levels were assessed in a hospital, while an extra aliquot of blood collected during routine blood collection after acquiring informed written consents from the subjects, and sent to Princess Al-Jawhara Center for Molecular Medicine and Inherited Disorders to be analyzed by ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS). Results: The mean age of the study group was 9±2 years. The mean total of 25(OH)D levels (D3 and D2) assessed by UPLC-MS/MS was 49.7±18.8, whereas the mean total of 25(OH)D levels obtained from the CMIA assay was 44.60±13.20. The difference in classification between the two methods was found to be statistically significant (P=0.004). A Bland–Altman plot showed a poor level of agreement between the two assay methods. The CMIA overestimated insufficient values and underestimated deficiency, when compared to UPLC-MS/MS. Conclusion: There was a statistically significant difference between the two assay methods with CMIA overestimating vitamin D insufficiency. Clinicians should be prudent in their assessment of a single vitamin D reading, when the gold standard method is not available or feasible. Keywords: type 1 diabetes, children, vitamin D, Middle East
- 1 January 2016
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. 9, 11-16
Open AccessAssessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain
Assessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain Fatima Ahmed Al-Haddad,1 Mansoor H Rajab,2 S Mahmood Al-Qallaf,3 Abdulrahman O Musaiger,4 Kathryn H Hart5 1Dietetic Unit for Hospitals, 2Pediatric Endocrine and Diabetes Team, Pediatric Department, Salmaniya Medical Complex, 3Pharmacy Program, College of Health Sciences, University of Bahrain, Manama, 4Nutrition and Health Studies Unit Deanship of Scientific Research, University of Bahrain, Sakheer, Kingdom of Bahrain; 5School of Biosciences and Medicine, Department of Nutritional Sciences, University of Surrey, Guildford, UK Background: The number of children being diagnosed with type 1 diabetes mellitus (T1DM) is on the rise and has more than doubled in the past 10 years in Bahrain. Some studies have linked low vitamin D levels with an increased risk of diabetes. There are concerns regarding the variations in circulating 25(OH)D levels measured by different laboratories and by using different analytical techniques. Objective: The aim of this study was to evaluate the vitamin D levels of newly diagnosed children with T1DM using the “gold standard method” with high-pressure liquid chromatography–tandem mass spectrometry methods compared to the chemiluminescence micro-particle immunoassay (CMIA) used in a hospital laboratory. Subjects: Eighteen children, aged 6–12 years, who received a confirmed diagnosis of T1DM in 2014 were chosen as subjects. Methods: Serum vitamin D levels were assessed in a hospital, while an extra aliquot of blood collected during routine blood collection after acquiring informed written consents from the subjects, and sent to Princess Al-Jawhara Center for Molecular Medicine and Inherited Disorders to be analyzed by ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS). Results: The mean age of the study group was 9±2 years. The mean total of 25(OH)D levels (D3 and D2) assessed by UPLC-MS/MS was 49.7±18.8, whereas the mean total of 25(OH)D levels obtained from the CMIA assay was 44.60±13.20. The difference in classification between the two methods was found to be statistically significant (P=0.004). A Bland–Altman plot showed a poor level of agreement between the two assay methods. The CMIA overestimated insufficient values and underestimated deficiency, when compared to UPLC-MS/MS. Conclusion: There was a statistically significant difference between the two assay methods with CMIA overestimating vitamin D insufficiency. Clinicians should be prudent in their assessment of a single vitamin D reading, when the gold standard method is not available or feasible. Keywords: type 1 diabetes, children, vitamin D, Middle East
- Open Access
- 31 March 2009
- Published by Wiley in British Journal of Pharmacology
- Vol. 156 (7) , 1124-1135
Atypical P2X7receptor pharmacology in two human osteoblast‐like cell lines
Background and purpose: The expression and function of P2X7receptors in osteoclasts is well established, but less is known about their role in osteoblast‐like cells. A study in P2X7receptor knockout mice suggested the involvement of these receptors in bone formation. We have investigated the expression and pharmacology of several P2X receptors in two human osteosarcoma cell lines to see if they could be involved in bone turnover in man.Experimental approach: Reverse transcriptase‐polymerase chain reaction and Western blotting were used to study P2X2, P2X4and P2X7receptor expression at mRNA and protein levels, respectively, in human osteoblast‐like cells. P2X7receptor pharmacology was studied by measuring pore formation in the presence of different agonists and antagonists using the YO‐PRO 1 uptake method.Key results: P2X4and P2X7receptor mRNA and protein were found to be expressed by these cell lines. No evidence was found for P2X4/P2X7receptor heteropolymerization. 2′‐3′‐O‐(4‐benzoylbenzoyl)adenosine 5′‐triphosphate (DBzATP) was equipotent to ATP and the antagonists used were either ineffective or weakly blocked pore formation.Conclusions and implications: This study demonstrates that P2X4and P2X7receptors are expressed by human osteoblast‐like cells. The affinities of the different agonists suggest that the P2X7receptor is mainly responsible for pore formation although P2X4receptors may also be involved. The low affinity of DBzATP and the weak action of the antagonists support the previously described atypical pharmacology of the P2X7receptor in osteoblasts. Targeting the P2X7receptor in osteoblasts could represent a promising new treatment for bone diseases such as osteoporosis and rheumatoid arthritis.
- 31 March 2009
- Published by Wiley in British Journal of Pharmacology
- Vol. 156 (7) , 1124-1135
Open AccessAtypical P2X7receptor pharmacology in two human osteoblast‐like cell lines
Background and purpose: The expression and function of P2X7receptors in osteoclasts is well established, but less is known about their role in osteoblast‐like cells. A study in P2X7receptor knockout mice suggested the involvement of these receptors in bone formation. We have investigated the expression and pharmacology of several P2X receptors in two human osteosarcoma cell lines to see if they could be involved in bone turnover in man.Experimental approach: Reverse transcriptase‐polymerase chain reaction and Western blotting were used to study P2X2, P2X4and P2X7receptor expression at mRNA and protein levels, respectively, in human osteoblast‐like cells. P2X7receptor pharmacology was studied by measuring pore formation in the presence of different agonists and antagonists using the YO‐PRO 1 uptake method.Key results: P2X4and P2X7receptor mRNA and protein were found to be expressed by these cell lines. No evidence was found for P2X4/P2X7receptor heteropolymerization. 2′‐3′‐O‐(4‐benzoylbenzoyl)adenosine 5′‐triphosphate (DBzATP) was equipotent to ATP and the antagonists used were either ineffective or weakly blocked pore formation.Conclusions and implications: This study demonstrates that P2X4and P2X7receptors are expressed by human osteoblast‐like cells. The affinities of the different agonists suggest that the P2X7receptor is mainly responsible for pore formation although P2X4receptors may also be involved. The low affinity of DBzATP and the weak action of the antagonists support the previously described atypical pharmacology of the P2X7receptor in osteoblasts. Targeting the P2X7receptor in osteoblasts could represent a promising new treatment for bone diseases such as osteoporosis and rheumatoid arthritis.